Board of Directors.

Dr. William Winkenwerder Jr. is the Chairman and CEO of Winkenwerder Strategies, a healthcare advisory and investment firm. He is an influential and very well recognized leader in American healthcare, with experience in medical care, healthcare finance and health insurance operations. Dr. Winkenwerder currently serves on the board of directors for several healthcare technology and services firms.

Dr. Winkenwerder served as Chief Executive Officer of Highmark Inc. till May 2014. Highmark is among the ten largest US health insurers and is the third largest integrated financing and delivery system, with $17.5 billion in annual revenues, based in Pittsburgh, PA, operating Blue Cross and Blue Shield Plans in three states and a $2.5 billion integrated hospital-physician network in western PA.

From 2001 to 2007, Dr. Winkenwerder served as the Assistant Secretary of Defense for Health Affairs handling 132,000 personnel, 9.2 million beneficiaries worldwide and an annual budget of $40 billion. Before that, he held senior leadership positions at Blue Cross of Massachusetts, Prudential Healthcare and Emory University. Dr. Winkenwerder is a Fellow of the American College of Physicians, and a board-certified physician who has practiced primary care medicine.

Dr. Winkenwerder graduated from the Davidson College and the University of North Carolina School of Medicine. He received his Master of Business Administration from the Wharton School of the University of Pennsylvania.

Pat Fry was the President and CEO of Sutter Health until his retirement in January 2016. He joined the Sutter organization in 1982 as an administrative resident at Sutter General Hospital in Sacramento, Calif. During his tenure, he worked his way up through the organization in increasingly responsible administrative positions both at the local affiliate and regional levels. Under his leadership, Sutter Health went on to become one of the nation’s leading healthcare systems.

Mr. Fry’s achievements include overseeing the implementation of one of the nation’s most sophisticated and comprehensive electronic health records, creation of the Sutter Medical Network, which unites Sutter’s 5,000 aligned and affiliated physicians and implementing My Health Online, which provides more than 1 million Northern Californians with anytime online access to their personal health records. He also led the growth of the Sutter Health Plus health plan. During Fry’s tenure, Sutter Health’s annual revenues grew from $6.7 billion to more than $10 billion. While consistently achieving strong financial performance during Fry’s tenure, Sutter Health made record investments in care for the underserved.

Mr. Fry also serves on the board of Verge Health and Vizient. He was also the chair of the California Hospital Association board of directors and has served on the American Hospital Association Governing Council and AHA Regional Policy board.

Anne McGeorge is the former Managing Partner of Grant Thornton’s Global Healthcare and Life Sciences Practice. She created the healthcare/life science practice for Grant Thornton and grew it to a $250 million global business in a little over ten years. Prior to Grant Thornton, Ms. McGeorge was a Partner at Deloitte and at Arthur Andersen LLP. Ms. McGeorge has over 35 years of experience advising healthcare clients in all aspects of finance and transformational change, including strategy, M&A, joint ventures, financial statement audits, corporate restructuring, governance, talent acquisition, executive compensation, IRS matters and risk management. In addition to her role as Board of Director, Ms. McGeorge chairs the Audit Committee of CitiusTech.

Ms. McGeorge is currently on the board of, and the audit committee chair of, Magenta Therapeutics (NASDAQ:MGTA) and SOC Telemed (NASDAQ:TLMD). She is also on the board of the Be The Match Foundation, supporting the $500M nonprofit that maintains the national database for bone marrow and stem cell transplants. She also serves on the Audit/ Finance and the New Technologies Committees, as well as serving as a “bone marrow courier,” transporting cells from donor to patient. She is also on the board of Dioko Health Ventures, a healthcare venture capital firm targeting early-stage investment opportunities with a focus on healthcare technology and operating partner of Havencrest Healthcare, a private equity firm targeting health care services and technology companies.

Ms. McGeorge is on the faculty of the University of North Carolina’s Gillings School of Global Public Health and is a past instructor for Duke University’s various post-graduate Certificate Programs. She is also a member of the Women Business Leaders in Healthcare.

Ms. McGeorge holds an MS degree in Accounting & Taxation from the University of Virginia and a BBA degree in Accounting from the College of William and Mary in Virginia. She has participated in numerous leadership development courses at the Harvard Business School.

Jimmy Mahtani is a Managing Director with Baring Private Equity. He has been with Baring Private Equity since 2006 and has led investments in IT services, financial services, infrastructure, education, and consumer goods companies. Previously, Mr. Mahtani has served as Vice-President at General Atlantic Partners (GAP). During his tenure at GAP, he was responsible for investments in technology and financial services sectors. Prior to that he has worked for Bear Stearns & Co. Inc. in New York and Merrill Lynch in Washington D.C.

Mr. Mahtani graduated with honors from Georgetown University, where he received a Bachelor's of Science in Business Administration with a triple major in finance, international business and marketing.

Hari Gopalakrishnan is a Managing Director with Baring Private Equity and invests in the technology and healthcare sectors. Mr. Gopalakrishnan joined Baring Private Equity in 2007 and is a founding member of its India business. Prior to joining Baring Private Equity, Mr. Gopalakrishnan worked in the private equity practice at New Vernon, a multi-strategy investment management firm. Previously, he worked for PricewaterhouseCoopers.

Mr. Gopalakrishnan has a Bachelor’s degree in Medicine and PGDM degree in Management from the Indian Institute of Management, Ahmedabad.

Pavninder Singh serves as the Managing Director at Bain Capital Private Equity, LP, as part of the Asia Pacific Private Equity team. He leads their efforts in India and Southeast Asia with a focus on Financial & Business Services and Industrial & Energy Verticals. Prior to that he was based in the New York Office as part of the North American Private Equity industrials team.

He has been closely involved with a number of Bain Capital’s investments in the region, including Axis Bank, Hero MotoCorp, JM Baxi, L&T Financial Services, Quest Engineering, Chindata, Emcure Pharmaceuticals and Brillio. He currently serves on the boards of Quest, JM Baxi, and Brillio. Prior to Bain, he served as a Co-Chief Executive Officer of Medrishi.com. He also served as a Consultant at Mercer Management Consulting, where he consulted in the e-commerce, retail and energy industries.
 
He received an M.B.A. from Harvard Business School, where he was a Baker Scholar. He received a B.A. degree from Harvard College